Investigational Site Number :6430001

Kemerovo 650002

0 studies enrolling now · 4 studies all time

What they study most

Chronic Kidney Diseases, Heart Failure, Hypercholesterolaemia, Type 2 Diabetes Mellitus

Studies at this site

• An Efficacy and Safety Study of Alirocumab in Children and Adolescents With Heterozygous Familial Hypercholesterolemia — Completed
• Effect of Sotagliflozin on Cardiovascular and Renal Events in Participants With Type 2 Diabetes and Moderate Renal Impairment Who Are at Cardiovascular Risk — Stopped early
• Effect of Efpeglenatide on Cardiovascular Outcomes — Stopped early
• An 8-Week Dose-Finding Study to Evaluate the Efficacy and Safety of Alirocumab in Children and Adolescents With Heterozygous Familial Hypercholesterolemia — Completed